Improved prognosis for older adolescents with acute lymphoblastic leukemia. - Wikidata - wikimedia - TriplyDB

Improved prognosis for older adolescents with acute lymphoblastic leukemia.

Improved prognosis for older adolescents with acute lymphoblastic leukemia.

http://www.wikidata.org/entity/Q34679298

about

Acute lymphoblastic leukaemia L-asparaginase in the treatment of patients with acute lymphoblastic leukemia Minimal residual disease diagnostics in acute lymphoblastic leukemia: need for sensitive, fast, and standardized technologies Childhood Acute Lymphoblastic Leukemia: Progress Through Collaboration Outcome of central nervous system relapses in childhood acute lymphoblastic leukaemia--prospective open cohort analyses of the ALLR3 trial Management of adult and paediatric acute lymphoblastic leukaemia in Asia: resource-stratified guidelines from the Asian Oncology Summit 2013.Treatment of adolescent and young adults with acute lymphoblastic leukemia Blood consult: therapeutic strategy and complications in the adolescent and young adult with acute lymphoblastic leukemia Biology, risk stratification, and therapy of pediatric acute leukemias: an update.Effective targeting of the P53-MDM2 axis in preclinical models of infant MLL-rearranged acute lymphoblastic leukemia.Challenging issues in pediatric oncology Acute lymphoblastic leukemia in children and adolescents: prognostic factors and analysis of survival Pediatric acute lymphoblastic leukemia: where are we going and how do we get there?Unique MRI findings as an early predictor of osteonecrosis in pediatric acute lymphoblastic leukemia.Minimal Residual Disease Evaluation in Childhood Acute Lymphoblastic Leukemia: A Clinical Evidence Review.Advances in the Biology of Acute Lymphoblastic Leukemia-From Genomics to the Clinic The adolescent and young adult with cancer: state of the art-- acute leukemias.A 50-year journey to cure childhood acute lymphoblastic leukemia Methylation of the DPH1 promoter causes immunotoxin resistance in acute lymphoblastic leukemia cell line KOPN-8.Risk-Benefit Analysis of Pediatric-Inspired Versus Hyperfractionated Cyclophosphamide, Vincristine, Doxorubicin, and Dexamethasone Protocols for Acute Lymphoblastic Leukemia in Adolescents and Young Adults.Optimal therapy for acute lymphoblastic leukemia in adolescents and young adults.Treatment of acute lymphoblastic leukemia in adolescents and young adults.The treatment of adolescents and young adults with acute lymphoblastic leukemia.Therapeutic approaches to haematological malignancies in adolescents and young adults.Thrombosis in pediatric cancer: identifying the risk factors to improve care.Philadelphia chromosome-negative acute lymphoblastic leukemia: therapies under development.Adolescent and young adult patients with cancer: a milieu of unique features.Vincristine Sulfate Liposomes Injection (VSLI, Marqibo®): Results From a Phase I Study in Children, Adolescents, and Young Adults With Refractory Solid Tumors or Leukemias.Drug design strategies focusing on the CXCR4/CXCR7/CXCL12 pathway in leukemia and lymphoma.Minimal residual disease-guided therapy in childhood acute lymphoblastic leukemia.Medication-induced diabetes during induction treatment for ALL, an early marker for future metabolic risk?Access to Children's Oncology Group and Pediatric Brain Tumor Consortium phase 1 clinical trials: Racial/ethnic dissimilarities in participation.The inferior prognosis of adolescents with acute lymphoblastic leukaemia (ALL) is caused by a higher rate of treatment-related mortality and not an increased relapse rate--a population-based analysis of 25 years of the Austrian ALL-BFM (Berlin-Frank Real-world outcomes of treatment for acute lymphoblastic leukemia during adolescence in a financially restricted environment: Results at a single center in Latin America.Outcome of adolescent patients with acute myeloid leukemia treated with pediatric protocols.Recent advances in the management of pediatric acute lymphoblastic leukemia.Treatment outcomes of adolescent acute lymphoblastic leukemia treated on Tokyo Children's Cancer Study Group (TCCSG) clinical trials.An adolescent with suspected intracranial hypertension - ALL is not what it seems.Efficacy and toxicity of a paediatric protocol in teenagers and young adults with Philadelphia chromosome negative acute lymphoblastic leukaemia: results from UKALL 2003.Surveillance and survival among adolescents and young adults with cancer in Ontario, Canada.

P2860

Q24602387-FB45A772-E8DC-4122-9E88-46F93B9DC402 Q26738640-B79D14A9-EE20-46BE-80D7-123165B70935 Q26828511-B3FB6FAB-7430-44A9-9864-E7AE3ECC8A13 Q28087637-28DA0D81-3CA3-4F07-A40C-A07946A59AF1 Q28543517-26E7920B-6DB5-4C46-B6E3-5C2F4A77B868 Q33762835-3DF8D611-D5B2-497F-B432-C45709540759 Q33920153-7AC67970-401F-48B2-9EB0-C58CCE8ED509 Q34009088-DAD1746C-6E25-40B3-8032-4D4879BEC668 Q34764504-4CB8FBF4-19A4-48D0-96A0-8D6C08732F3C Q35178411-1D81FE29-B8CA-4E2A-BE98-86C04875CE5B Q35602419-13966B6F-B336-49A0-AEE8-95C5D096FC00 Q35901969-A3454E95-D5F0-47D5-AD82-16F33BFFC44B Q36163029-A36C37CF-CC13-4171-91C9-601BE41DE946 Q36422310-88D57908-F755-439F-AB33-E18BF11DAAEB Q36731636-6820A005-C7A0-404D-998C-D459C86E2F58 Q36752634-98873C19-93A5-4887-AF55-16A383997DB5 Q37134753-1A68A9E0-F668-4595-A5BC-06984178E7E2 Q37166753-726BC9EC-1021-40A6-A8AD-1A7C055483F7 Q37282218-7AA06577-A469-4ADF-BE1E-A38FA23606C5 Q37695157-ECCD7771-75DA-4FA2-950F-DF066DD11D6A Q37883008-D28F6478-1A04-490A-83D8-ED32C1B27EC1 Q37899785-2D5B5891-DC70-4E51-BA5B-03E4308D94D3 Q38096307-CFC8F2C4-DFAF-4A0F-8B4B-9D9437C3D9BB Q38134399-4B810180-1B57-41BA-970A-F47589FAEE83 Q38152512-F20E290B-4504-4561-90D7-52C82AA89776 Q38282458-58237F0C-3CAC-47E2-AD7E-D100BA1BBE0C Q38502885-2692BF9F-86F9-4589-9715-48D156BC7510 Q38906405-4C502C16-3DBD-4B6C-A893-9A0B954A49C5 Q38947056-B9FA2CF6-F282-4DDF-8F71-CA3203D75EDC Q39123286-3137A2DF-A4A4-42C1-86B6-28CFC19FF3FC Q39221588-472DC650-6369-46E9-B449-01EC85522908 Q39610150-6F7D8559-FE02-4E57-923A-9EB566B40E1C Q40097280-49B86195-A0A8-480D-8D21-DADE7F6C85EF Q40427765-C1CBB8ED-495D-484F-B820-45699D249078 Q40781300-80BE5B42-5D14-47A5-98C0-4CA9B0610954 Q45105040-3A97B0BA-F41B-4627-B795-AF1A780A08BA Q51074196-15DC6E1B-937E-48CF-8414-B4154F2F48DF Q53178007-4250467C-50C4-442B-811D-A1526F22CDEE Q53239133-44E94002-E59A-4446-A9AB-08C65B73C191 Q53649438-244E378A-489A-4115-8460-0D0A6AD16452

P2860

Improved prognosis for older adolescents with acute lymphoblastic leukemia.

http://www.wikidata.org/entity/Q34679298

description

2010 nî lūn-bûn

@nan

2010 թուականի Դեկտեմբերին հրատարակուած գիտական յօդուած

@hyw

2010 թվականի դեկտեմբերին հրատարակված գիտական հոդված

@hy

2010年の論文

@ja

2010年学术文章

@wuu

2010年学术文章

@zh-cn

2010年学术文章

@zh-hans

2010年学术文章

@zh-my

2010年学术文章

@zh-sg

2010年學術文章

@yue

name

Improved prognosis for older adolescents with acute lymphoblastic leukemia.

@ast

Improved prognosis for older adolescents with acute lymphoblastic leukemia.

@en

Improved prognosis for older adolescents with acute lymphoblastic leukemia.

@nl

type

label

Improved prognosis for older adolescents with acute lymphoblastic leukemia.

@ast

Improved prognosis for older adolescents with acute lymphoblastic leukemia.

@en

Improved prognosis for older adolescents with acute lymphoblastic leukemia.

@nl

prefLabel

Improved prognosis for older adolescents with acute lymphoblastic leukemia.

@ast

Improved prognosis for older adolescents with acute lymphoblastic leukemia.

@en

Improved prognosis for older adolescents with acute lymphoblastic leukemia.

@nl

P1433

Q34679298-6D707305-9209-411B-B03F-776CD50A0B24

P1476

Q34679298-881FEAD8-26C6-4347-AA8C-EF23A52E2672

P2093

Q34679298-067315C9-C875-454B-808E-E1AE69573946

Q34679298-1C90BE9F-1643-46F9-AE94-722F437F5DA9

Q34679298-1E8FCCEA-1C7A-4F0D-8A4A-1605707B3EAD

Q34679298-406911E2-B87A-4A50-93D6-9A97AE5038EC

Q34679298-4AB1B923-121E-4B94-8D15-F17F13FB688C

Q34679298-7565F0F4-E823-4AD6-B4AD-5F884ABF369F

Q34679298-7EE082E3-D649-42B0-B4C5-72C3ABAF551E

Q34679298-98407235-7E13-401B-8279-637CDC0AB0FE

Q34679298-AB8F40FE-9D4C-4D5F-BAD0-6FB341E2CE36

Q34679298-B43DB27A-D27B-42A0-A591-702698A00CB9

P2860

Q34679298-104AE63C-A679-48A4-9354-9A4A43FE8B6B

Q34679298-182F0CE7-E0D6-4045-AA6B-BCC2A9C09C56

Q34679298-253D8AE0-315C-4E59-A641-CBFEF14927FD

Q34679298-26A18177-9A14-4D40-9169-AD842BEE4874

Q34679298-28A906E0-71A0-4803-84B2-39FB3B422408

Q34679298-2AAA6FDE-A218-438C-9F56-0C3D427F854F

Q34679298-3ABC1A29-DE2D-412B-BB22-DF751CDB6E5D

Q34679298-4392D288-E1D8-4AE1-A40A-7987B3500BB1

Q34679298-447B975A-03FC-4DD7-87AB-70677FF7E930

Q34679298-4649228F-8370-461F-B0FD-4955F5421097

P304

Q34679298-C8CC70FB-0E40-4829-8B4D-152C4F41F00A

P31

Q34679298-7E3AF2EA-D01E-401E-BE52-C2A4AA71325D

P356

Q34679298-7C1F1074-B651-4CCA-A8E4-2328BAD436F8

P407

Q34679298-B49018AA-A4E4-4605-8003-640E296F353F

P433

Q34679298-DF10043E-E170-4D00-B32B-126F20B36DFB

P478

Q34679298-98B27522-E0C1-449A-96CA-FEA51533547F

P50

Q34679298-3668BE4E-D997-481B-9255-5D0AD526AD50

Q34679298-374F54A9-50FF-425F-89EB-4DFFF7EE3C2A

P577

Q34679298-0160DD8D-E1EB-4B95-895B-3FA3ACA9F79C

P698

Q34679298-CDE09F81-0B99-4C1B-AF8D-BDA3F6F2BD0F

P921

Q34679298-9FBE70B7-AF08-43EC-BB56-1031C8C28334

Q34679298-AF9CB489-62CE-4675-9715-D66B45F516C4

P932

Q34679298-D1A1D3DE-01A3-4100-969B-206B87DBF53C

P356

JCO.2010.32.0325

P1433

Journal of Clinical Oncology

P1476

Improved prognosis for older adolescents with acute lymphoblastic leukemia

@en

P2093

Cheng Cheng

http://www.w3.org/2001/XMLSchema#string

Ching-Hon Pui

http://www.w3.org/2001/XMLSchema#string

Dario Campana

http://www.w3.org/2001/XMLSchema#string

Deqing Pei

http://www.w3.org/2001/XMLSchema#string

Elaine Coustan-Smith

http://www.w3.org/2001/XMLSchema#string

Hiroto Inaba

http://www.w3.org/2001/XMLSchema#string

James R Downing

http://www.w3.org/2001/XMLSchema#string

John T Sandlund

http://www.w3.org/2001/XMLSchema#string

Mary V Relling

http://www.w3.org/2001/XMLSchema#string

Mihaela Onciu

http://www.w3.org/2001/XMLSchema#string

P2860

Treating childhood acute lymphoblastic leukemia without cranial irradiation

Folate pathway gene expression differs in subtypes of acute lymphoblastic leukemia and influences methotrexate pharmacodynamics

Long-term results of St Jude Total Therapy Studies 11, 12, 13A, 13B, and 14 for childhood acute lymphoblastic leukemia.

Long-term follow-up of the United Kingdom medical research council protocols for childhood acute lymphoblastic leukaemia, 1980-2001

Early T-cell precursor leukaemia: a subtype of very high-risk acute lymphoblastic leukaemia

Improved outcome in childhood acute lymphoblastic leukemia despite reduced use of anthracyclines and cranial radiotherapy: results of trial ALL-BFM 90. German-Austrian-Swiss ALL-BFM Study Group.

Long-term results of the children's cancer group studies for childhood acute lymphoblastic leukemia 1983-2002: a Children's Oncology Group Report.

Comparison of Escherichia coli-asparaginase with Erwinia-asparaginase in the treatment of childhood lymphoid malignancies: results of a randomized European Organisation for Research and Treatment of Cancer-Children's Leukemia Group phase 3 trial.

Young adults with acute lymphoblastic leukemia have an excellent outcome with chemotherapy alone and benefit from intensive postinduction treatment: a report from the children's oncology group.

Biology, risk stratification, and therapy of pediatric acute leukemias: an update.

P304

386-391

http://www.w3.org/2001/XMLSchema#string

P31

scholarly article

P356

10.1200/JCO.2010.32.0325

http://www.w3.org/2001/XMLSchema#string

P407

P433

4

http://www.w3.org/2001/XMLSchema#string

P478

29

http://www.w3.org/2001/XMLSchema#string

P50

Jeffrey Rubnitz

P577

2010-12-20T00:00:00Z

http://www.w3.org/2001/XMLSchema#dateTime

P698

21172890

http://www.w3.org/2001/XMLSchema#string

P921

P932

3058285

http://www.w3.org/2001/XMLSchema#string